News Conference News EuroPCR 2023 MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact Caitlin E. Cox May 19, 2023
News Conference News EuroPCR 2023 Many ACS Patients With Occlusions Are Falling Through the Cracks Todd Neale May 19, 2023
News Conference News EuroPCR 2022 Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients Yael L. Maxwell May 27, 2022
News Conference News EuroPCR 2022 Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO Yael L. Maxwell May 23, 2022
News Conference News EuroPCR 2022 TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days Yael L. Maxwell May 19, 2022
News Conference News EuroPCR 2019 Newer-Generation MitraClip XTR Shows Promise, but Beware the Learning Curve Shelley Wood May 27, 2019
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2017 DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting Yael L. Maxwell May 22, 2017
News Conference News EuroPCR 2016 ‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small Shelley Wood May 26, 2016
News Conference News EuroPCR 2016 Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up Shelley Wood May 20, 2016
News Conference News EuroPCR 2015 DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device Yael L. Maxwell May 20, 2015
News Conference News EuroPCR 2012 CIBELES: Xience Stands Up to Cypher for CTO PCI Caitlin E. Cox May 17, 2012